Structure Therapeutics Inc. logo

Structure Therapeutics Inc. (GPCR)

Market Closed
27 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
48. 69
-0.43
-0.8754%
$
2.9B Market Cap
- P/E Ratio
- Div Yield
458,259 Volume
- Eps
$ 49.12
Previous Close
Add Transaction
Day Range
48.69 51.3
Year Range
15.8 94.9
Want to track GPCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Structure Therapeutics Inc. logo
GPCR Structure Therapeutics Inc.
6 May 2026
-
-
Structure Therapeutics Inc. logo
GPCR Structure Therapeutics Inc.
26 Mar 2026
-
0.2
Structure Therapeutics Inc. logo
GPCR Structure Therapeutics Inc.
26 Feb 2026
-
-
Structure Therapeutics Inc. logo
GPCR Structure Therapeutics Inc.
6 Nov 2025
-
-
Structure Therapeutics Inc. logo
GPCR Structure Therapeutics Inc.
7 Aug 2025
-
-
Structure Therapeutics Inc. logo
GPCR Structure Therapeutics Inc.
12 May 2025
-
-
Structure Therapeutics Inc. logo
GPCR Structure Therapeutics Inc.
27 Mar 2025
-
-
Structure Therapeutics Inc. logo
GPCR Structure Therapeutics Inc.
15 Nov 2024
-
-
Structure Therapeutics Inc. logo
GPCR Structure Therapeutics Inc.
9 Aug 2024
-
-
Structure Therapeutics Inc. logo
GPCR Structure Therapeutics Inc.
9 May 2024
-
-

GPCR Earnings Reports FAQ

What is the earnings per share (EPS) for GPCR?

EPS data for GPCR is currently not available, as Structure Therapeutics Inc has not reported recent earnings.

What is the company's earnings growth rate?

Structure Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Structure Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Structure Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for GPCR at this time, as Structure Therapeutics Inc has no recent EPS data to calculate it.